Logo for bioMérieux S.A

bioMérieux Investor Relations Material

Latest events

Logo for bioMérieux S.A

H2 2023

bioMérieux
Logo for bioMérieux

H2 2023

14 Mar, 2024
Logo for bioMérieux

Q3 2023

26 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from bioMérieux S.A

Access all reports
bioMérieux S.A. is a worldwide leader in the manufacture, marketing, and distribution of in vitro diagnostics for human and animal health applications. With sales that exceeded €1 billion for the first time in 2016, bioMérieux offers close to 20,000 products marketed under the brand names of ELITechGroup Pharma-Vet, bioMérieux Analyzer, molecular subsidiaries TA Systems and RED-BioSys Medical Insurance Company; Immedica, a provider of managed clinical care programs; BioFire Defense LLC (a wholly owned subsidiary), an integrated forensic product line; BD and Embletta which are joint ventures with Becton Dickinson & Company and Synlab Holding S.r.l., respectively; AxioMed Life Technologies Inc., a US company owning the patents associated with knee joint replacement implants Actifuse Foot Fusion System (AFFS) and same named prostheses; and Emmesure Inc., launched in 2013 to develop enhanced solutions for clinical laboratories through collaborations with small companies.